Doctor talking to a female patient in the hospital corridor.
© [M] Munich Re [1] shapecharge / Getty Images

Improving Cancer Outcomes

Monitoring advances in cancer treatment and research

Life Science Report 2025

    alt txt

    properties.trackTitle

    properties.trackSubtitle

    Although still the leading cause of death among policyholders, cancer is increasingly becoming a manageable disease, reshaping the entire insurance landscape. The rise of personalized medicine and AI-driven diagnostics is revolutionizing how we prevent, detect, and treat cancer. As medical research continues to advance in this field, it is crucial for insurers to closely monitor the implications for insurance products and healthcare costs.

    Munich Re's Life Science Report provides a comprehensive guide to assessing both the promises and pitfalls of emerging medical trends and risks, helping life and health insurers to better navigate this environment of changing mortality and morbidity. The report examines the topics of Artificial Intelligence in Healthcare, Improving Cancer Outcomes, Prevention, Obesity and Climate Change.

    Improving Cancer Outcomes – Key Facts

    Cancer research advances drive significant mortality improvements, changing how cancers are defined, prevented, diagnosed, and treated. ​
    AI-driven prevention efforts improve cancer risk prediction, allowing for better risk reduction and more accurate underwriting assessment while requiring the need to monitor potential anti-selective behavior.
    AI-fueled diagnostic advances and liquid biopsies enable earlier cancer detection and improved risk stratification, requiring updates to product definitions and cancer classification. ​
    Personalized therapies, including targeted drug development and immunotherapies, continue to evolve, with potentially significant impact on outcomes – and on healthcare costs.

    Improving Cancer Outcomes

    Explore our edition on "Improving Cancer Outcomes" and find out more about the implications for life and health insurers.

    Explore the Life Science Report

    Subscribe to newsletter for other topics

    Stay tuned for the other topics in our Life Science Report 2025. Over five editions published in the first quarter of 2025, our global medical team will explore key trends and risks that have the potential to reshape the mortality and morbidity landscape: 

    • Artificial Intelligence in Healthcare,
    • Improving Cancer Outcomes,
    • Prevention,
    • Obesity,
    • Climate Change. 

    The report provides life and health insurers an actionable guide to prepare for the underlying business implications. Sign up for email updates on upcoming editions. Please note that we will contact you once to ask for your consent for further communication according to our privacy policy

    Please enter a value. This selection is mandatory.
    Please enter a value.
    Please enter a value.
    Please enter your e-mail address.
    Thank you for your message. Your message has been sent to our Life Science Report team.
    Something went wrong please try again!

    Contact our experts

    Gina Guzman
    Dr. Gina Guzman
    Vice President & Chief Medical Director
    Munich Re Life US
    Timothy Meagher
    Dr. Tim Meagher
    Vice President & Medical Director
    Munich Re, Canada (Life)
    Bradley Heltemes
    Dr. Bradley Heltemes
    Vice President & Medical Director of R&D
    Munich Re Life US
    Alban Senn
    Dr. Alban Senn
    Chief Medical Officer, Head of Medical Research & Development
    Munich Re Life & Health
    Europe & Latin America
    Javier Gracia San Román
    Dr. Javier Gracia San Román
    Chief Medical Officer
    Munich Re Life & Health
    Southern Europe & Latin America
    Mathias Orban
    Prof. Dr. Mathias Orban
    Senior Medical Consultant
    Munich Re Life & Health
    Europe & Latin America
    Christiane Suchy
    Dr. Christiane Suchy
    Medical Consultant
    Munich Re Life & Health
    Europe & Latin America
    Andreas Armuss
    Dr. Andreas Armuss
    Chief Medical Officer
    Munich Re Life & Health
    Asia-Pacific, Middle East & Africa
    Matthew Paul
    Dr. Matthew Paul
    Chief Medical Officer
    Munich Re Life & Health
    Australia & New Zealand
    Hao Liu
    Dr. Hao Liu
    Chief Medical Proposition Officer
    Munich Re Life & Health
    Asia-Pacific
    Jaee Menon
    Dr. Jaee Menon
    Chief Medical Consultant
    Munich Re Life & Health
    South Asia, Southeast Asia, GCC